Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Thomas, M. [1 ,2 ]
Kohlhaeufl, M. [3 ]
Reck, M. [4 ]
Engel-Riedel, W. [5 ]
Kortsik, C. [6 ]
Bullinger, L. [7 ]
Schneider, C. -P. [8 ]
Felip, E. [9 ]
Brahmer, J. [10 ]
Vokes, E. [11 ]
Gettinger, S. [12 ]
Geese, W. [13 ]
Yoon, D. [13 ]
Healey, D. [13 ]
Li, A. [13 ]
Eberhardt, W. E. E. [14 ,15 ]
机构：
[1] Univ Klinikum Heidelberg, TLRC H, Internist Onkol Thoraxtumoren, Thoraxklin, Heidelberg, Germany
[2] German Ctr Lung Res DZL, Heidelberg, Germany
[3] Robert Bosch Krankenhaus, Stuttgart, Germany
[4] LungenClin Grosshansdorf, Grosshansdorf, Germany
[5] Kliniken Stadt Koln gGmbh, Krankenhaus Mehrheim, Cologne, Germany
[6] Katholisches Klinikum Mainz, Lungenzentrum, Mainz, Germany
[7] Univ Klinikum Ulm, Ulm, Germany
[8] Zent Klin Bad Berka Gmbh, Bad Berka, Germany
[9] Vall dHebron Univ Hosp, Barcelona, Spain
[10] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[11] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[12] Yale Canc Ctr, New Haven, CT USA
[13] Bristol Myers Squibb, Princeton, NJ USA
[14] Univ Duisburg Essen, Univ Hosp, Essen, Germany
[15] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V510
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [41] Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
    Ramagopalan, Sreeram
    Gupta, Alind
    Arora, Paul
    Thorlund, Kristian
    Ray, Joshua
    Subbiah, Vivek
    [J]. JAMA NETWORK OPEN, 2021, 4 (11)
  • [42] Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Alonso-Garcia, Miriam
    Sanchez-Gastaldo, Amparo
    Munoz-Fuentes, Miguel A.
    Molina-Pinelo, Sonia
    Boyero, Laura
    Benedetti, Johana Cristina
    Bernabe-Caro, Reyes
    [J]. PHARMACEUTICALS, 2022, 15 (05)
  • [43] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [44] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [45] Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Cusato, Jessica
    Genova, Carlo
    Tomasello, Cristina
    Carrega, Paolo
    Ottonello, Selene
    Pietra, Gabriella
    Mingari, Maria Cristina
    Cossu, Irene
    Rijavec, Erika
    Leggieri, Anna
    Di Perri, Giovanni
    Dal Bello, Maria Giovanna
    Coco, Simona
    Boccardo, Simona
    Ferlazzo, Guido
    Grossi, Francesco
    D'Avolio, Antonio
    [J]. CANCERS, 2019, 11 (01):
  • [46] Clinical features of patients with advanced non-squamous non-small cell lung cancer treated with long-term pemetrexed
    Hirai, Kenichiro
    Yokouchi, Hiroshi
    Azuma, Keisuke
    Minemura, Hiroyuki
    Sekine, Satoko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 123 - 123
  • [47] LONG-TERM ERLOTINIB THERAPY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): INTERIM ANALYSIS OF BASELINE CHARACTERISTICS
    Chouaid, C.
    Gervais, R.
    Locher, C.
    Moro-Sibilot, D.
    Commenges, B.
    Chenoufi, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 446 - 446
  • [48] SAPPHIRE: Phase III study of sitravatinib plus nivolumab versus docetaxel in patients with previously treated advanced non-squamous non-small cell lung cancer (NSCLC)
    Borghaei, H.
    Johnson, M. L.
    Garon, E. B.
    He, K.
    Planchard, D.
    Reck, M.
    Popat, S.
    Herbst, R. S.
    Leal, T. A.
    Dumoulin, D.
    De Marinis, F.
    Reynolds, C. H.
    Theelen, W. S. M. E.
    Percent, I.
    Calderon, V. Gutierrez
    Flandin, A. C. Madroszyk
    Shazer, R. L.
    Yan, X.
    Harrigan, R.
    Peters, S.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1308 - S1308
  • [49] EARLY CLOSURE OF A CLINICAL TRIAL OF DICHLOROACETATE IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND BREAST CANCER
    Garon, Edward B.
    Hosmer, Wylie
    Britten, Carolyn
    Kabbinavar, Fairooz
    Michelakis, Evangelos D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1217 - S1218
  • [50] Durvalumab (D) in combination with olaparib (O) for advanced, previously treated non-small cell lung cancer (NSCLC).
    Desmond, Daniel
    Vilimas, Rasa
    Mullenix, Cristina
    Zhao, Chen
    Szabo, Eva
    Shelat, Meenakshi
    Ballman, Madison
    Sansone, Susan
    Steinberg, Seth M.
    Lee, Jung-Min
    Rajan, Arun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345